John G. Melo is the Chief Executive Officer of Amyris Biotechnologies, a synthetic biology company working to reduce the cost of curing malaria and producing lower carbon, second generation bio-fuels.
He was previously president of U.S. Fuels for BP, where he led one of the world's largest petroleum marketing, logistics, and trading businesses. While in this role he successfully grew revenues from $25 billion to $34 billion and increased net cash by $1 billion. During this time his team developed one of the world's most successful ethanol blending and marketing businesses. He also worked on the development of BP's "Helios" re-branding.
Prior to his eight years with BP, Mr. Melo was a director with Ernst & Young in San Jose, California, and a management team member for several Northern California start-ups, including Computer Aided Services and Alldata Corporation.
John serves on the Board of Directors for U.S. Oil, a $1.6 billion energy company, and Cilion, a leading low-cost ethanol manufacturer.
John is a member of the Economic Club of Chicago, The Chicago Club, The Chicago Council on Global Affairs, and YPO. He enjoys visiting his home country of Azores, Portugal, as well as skiing, biking, tennis, golf, and time with his children.
Related Links: http://www.amyrisbiotech.com/
Last Updated: Sat, Oct 25, 2008
|Video||Attracting Promising Talent||John Melo||Amyris||03:35||05/2008|
|Video||Planning for the Market||John Melo||Amyris||03:36||05/2008|
|Video||Synthetic Biology in Action||John Melo||Amyris||03:47||05/2008|
|Video||Comparing Start-Ups to Fortune 500||John Melo||Amyris||03:52||05/2008|
|Video||Do What You Like to Get Where You Want||John Melo||Amyris||03:56||05/2008|
|Video||Driving Low Cost and Time to Market||John Melo||Amyris||05:33||05/2008|
|Podcast||Under the Microscope: Socially Responsible Biotech||John Melo||Amyris||59:07||05/2008|